Seer Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Outlook
March 02, 2023 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., March 02, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
Seer to Present at the Cowen 43rd Annual Health Care Conference
February 21, 2023 16:30 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company...
Seer to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023
February 09, 2023 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will...
Seer to Present at the J.P. Morgan 41st Annual Health Care Conference
December 27, 2022 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company...
Seer’s Proteomics Platform Named as Top 10 Innovation in 2022 by The Scientist
December 12, 2022 10:00 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the...
Seer Reports Third Quarter 2022 Financial Results
November 08, 2022 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...
Seer to Report Third Quarter 2022 Financial Results on November 8, 2022
October 13, 2022 16:15 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will report...
Seer to Participate in the Morgan Stanley Global Healthcare Conference
August 30, 2022 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that the company...
Seer Announces Publication of Seminal Study Demonstrating the Power of Engineered Nano-Bio Interactions to Enable Deep Access to the Proteome
August 23, 2022 08:00 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Aug. 23, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) today announced the publication of a study demonstrating the performance of the technology underlying the...
Seer Reports Second Quarter 2022 Financial Results
August 09, 2022 16:05 ET
|
Seer, Inc.
REDWOOD CITY, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today reported financial results...